肠微生态移植供体筛选新标准的研究

注册号:

Registration number:

ChiCTR2200055151 

最近更新日期:

Date of Last Refreshed on:

2023-01-15 20:30:03 

注册时间:

Date of Registration:

2022-01-01 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

肠微生态移植供体筛选新标准的研究

Public title:

Research on new criteria for the selection of intestinal microecological transplant donors

注册题目简写:

English Acronym:

研究课题的正式科学名称:

肠微生态移植供体筛选新标准的研究

Scientific title:

Research on new criteria for the selection of intestinal microecological transplant donors

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

马心怡 

研究负责人:

杨云生 

Applicant:

Ma Xinyi 

Study leader:

Yang Yunsheng 

申请注册联系人电话:

Applicant telephone:

+86 13212109816

研究负责人电话:

Study leader's
telephone:

+86 10 68154653

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

joycemxy@163.com

研究负责人电子邮件:

Study leader's E-mail:

sunnyddc@plagh.org

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

北京市海淀区复兴路中国人民解放军总医院第一医学中心

研究负责人通讯地址:

北京市海淀区复兴路中国人民解放军总医院第一医学中心

Applicant address:

Fuxing Road, Haidian District, Beijing

Study leader's address:

Fuxing Road, Haidian District, Beijing

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

中国人民解放军总医院第一医学中心

Applicant's institution:

The First Medical Center of the Chinese People's Liberation Army General Hospital

研究负责人所在单位:

中国人民解放军总医院第一医学中心

Affiliation of the Leader:

The First Medical Center of the Chinese People's Liberation Army General Hospital

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

S2021-602-01

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

中国人民解放军总医院医学伦理委员会

Name of the ethic committee:

Ethics Committee of Chinese PLA General Hospital

伦理委员会批准日期:

Date of approved by ethic committee:

2021-11-30 00:00:00

伦理委员会联系人:

曹江

Contact Name of the ethic committee:

Cao Jiang

伦理委员会联系地址:

北京市海淀区复兴路中国人民解放军总医院第一医学中心

Contact Address of the ethic committee:

Fuxing Road, Haidian District, Beijing

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

中国人民解放军总医院第一医学中心

Primary sponsor:

The First Medical Center of the Chinese People's Liberation Army General Hospital

研究实施负责(组长)单位地址:

北京市海淀区复兴路中国人民解放军总医院第一医学中心

Primary sponsor's address:

Fuxing Road, Haidian District, Beijing

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

北京

市(区县):

Country:

China

Province:

Beijing

City:

单位(医院):

中国人民解放军总医院第一医学中心

具体地址:

海淀区复兴路

Institution
hospital:

The First Medical Center of the Chinese People's Liberation Army General Hospital

Address:

Fuxing Road, Haidian District

经费或物资来源:

医院科研课题

Source(s) of funding:

Hospital research projects

研究疾病:

N/A  

Target disease:

N/A

研究疾病代码:

Target disease code:

研究类型:

观察性研究

Study type:

Observational study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

连续入组 

Study design:

Sequential 

研究目的:

建立 1 套肠微生态移植供体选择和筛查新流程和标准,基于新标准筛选出可以临床应用的健康供体 1-4 人。  

Objectives of Study:

Establish a new set of procedures and standards for the selection and screening of intestinal microecological transplant donors, and screen out 1-4 healthy donors who can be clinically applied based on the new standards.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

Inclusion criteria

排除标准:

1.未通过问卷筛选的人群;
2.未通过相关实验室检验及检查的人群;
3.PCR筛查出相关致病菌及耐药基因的人群。

Exclusion criteria:

1. Those who did not pass the questionnaire screening;
2. Patients who have not passed relevant laboratory tests and inspections;
3. PCR screening of related pathogenic bacteria and the population of drug resistance genes.

研究实施时间:

Study execute time:

From 2022-01-01 00:00:00 To 2022-12-30 00:00:00  

征募观察对象时间:

Recruiting time:

From 2022-01-01 00:00:00 To 2022-12-30 00:00:00

干预措施:

Interventions:

组别:

连续入组

样本量:

1500

Group:

case series

Sample size:

干预措施:

干预措施代码:

Intervention:

none

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

北京 

市(区县):

 

Country:

China

Province:

Beijing

City:

单位(医院):

中国人民解放军总医院第一医学中心 

单位级别:

三级甲等 

Institution
hospital:

The First Medical Center of the Chinese People's Liberation Army General Hospital

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

粪常规

指标类型:

主要指标

Outcome:

routine stool test

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

粪便

组织:

Sample Name:

feces

Tissue:

人体标本去向

使用后销毁  

说明

Fate of sample:

Destruction after use  

Note:

标本中文名:

血液

组织:

Sample Name:

blood

Tissue:

人体标本去向

使用后销毁  

说明

Fate of sample:

Destruction after use  

Note:

征募研究对象情况:

Recruiting status:

正在进行

Recruiting

年龄范围:

Participant age:

最小 Min age 6 years
最大 Max age 35 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

本研究为筛查项目,不涉及随机方法

Randomization Procedure (please state who generates the random number sequence and by what method):

This research is a screening project and does not involve random methods

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

不公开/Private

盲法:

N/A

Blinding:

N/A

是否共享原始数据:

IPD sharing

否No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

不共享

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

Do not share data

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

病例记录表;Excel管理电子数据

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

CRF; Excel

数据与安全监察委员会:

Data and Safety Monitoring Committee:

无/No

注册人:

Name of Registration:

 2022-01-01 23:42:59